Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mastocytosis, Systemic 2Leukemia, Mast-Cell 2Congenital Abnormalities 2Aggression 2Neoplasm, Residual 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1GATA2 Deficiency 1

Interventions

Cytarabine 21fludarabine phosphate 8Busulfan 8Daunorubicin 7Peripheral Blood Stem Cell Transplantation 6Mitoxantrone 6Idarubicin 6Methotrexate 5Gemtuzumab 5Filgrastim 5Etoposide 5Clofarabine 5tipifarnib 4Whole-Body Irradiation 4Vorinostat 4Tacrolimus 4Cyclosporine 4Cyclophosphamide 4Antilymphocyte Serum 4sargramostim 3alvocidib 3Observation 3Mycophenolic Acid 3Flow Cytometry 3Decitabine 3Cytogenetic Analysis 3Azacitidine 3aldesleukin 2Pravastatin 2In Situ Hybridization, Fluorescence 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Megakaryoblastic, Acute × midostaurin × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡